• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® DRYSEAL FLEX INTRODUCER SHEATH; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® DRYSEAL FLEX INTRODUCER SHEATH; INTRODUCER, CATHETER Back to Search Results
Catalog Number DSF2633
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Intimal Dissection (1333); Aortic Dissection (2491); Blood Loss (2597); Vascular Dissection (3160)
Event Date 12/11/2017
Event Type  Injury  
Manufacturer Narrative
(b)(4).Medical devices: the patient¿s medications include; acetaminophen, atorvastatin, cholecalciferol, clopidogrel, colace, cyanocobalamin, ferrous furamate, levetiracetam, levothyroxine, losartan, metoprolol succinate, oxycodone, plavix and vitamin b-12.The review of the manufacturing paperwork verified that this lot met all pre-release specifications.According to the gore® dryseal flex introducer sheath instructions for use (ifu), adequate vessel access is required to introduce the sheath into the vasculature.Careful evaluation of vessel size, anatomy, tortuosity, and disease state (including calcification, plaque, and thrombus) is required to ensure successful sheath introduction and subsequent withdrawal.If vessel is not adequate for access, major bleeding, vascular trauma (i.E., dissection, rupture, perforation, tear, etc.), or serious injury to the patient may result.
 
Event Description
The following information was reported to gore through the pivotal study for the gore® tag® thoracic branch endoprosthesis (tbe device): on (b)(6) 2017, pre-implantation imaging identified a zone 0/1 aortic aneurysm with a maximum diameter of 66mm and a length of 7cm.It was reported the right external iliac/femoral artery measured 10mm in diameter.On (b)(6) 2017, the patient underwent treatment of the aortic aneurysm, with two gore® tag® thoracic branch endoprostheses.According to the report, a 26 fr gore® dryseal flex sheath was advanced through the right external iliac artery and both endoprostheses were positioned and deployed without issue.Successful access and delivery to the intended implantation site and retrieval of the device delivery system was reported.Intra-procedural angiography confirmed exclusion of the aneurysm and full patency of the aortic and side branch components.According to the report, after removing the sheath, there was an apparent significant disruption of the intimal anterior wall of the right common femoral artery.Blood loss of greater than 1 liter was reported and a transfusion of 2 units of blood products was administered.An additional procedure was performed consisting of localized endarterectomy, with transection of the torn femoral artery and interposition repair of the artery with implantation of an advanta¿ vxt ptfe vascular graft (10mmx80cm).At the conclusion of the procedure, it was reported the patient had palpable pulses with strong pulse volume recording signals.No further complications were reported and the patient tolerated the procedure.According to the report, no resistance was encountered during the advancement or withdrawal of the sheath.The exact cause of the dissection is reportedly unknown, however it was reported the patient's right common femoral artery was reported as "friable".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® DRYSEAL FLEX INTRODUCER SHEATH
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL PHOENIX 1 B/P
32360 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
charlene cooper
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key7179046
MDR Text Key96869824
Report Number3007284313-2018-00009
Device Sequence Number1
Product Code DYB
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K160254
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type study
Reporter Occupation Physician
Type of Report Initial
Report Date 12/22/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/10/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/02/2020
Device Catalogue NumberDSF2633
Device Lot Number1V400175
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/30/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age76 YR
Patient Weight75
-
-